AbbVie Lowers Full-Year Profit Guidance, Investor Disappointment Triggers Stock Sell-Off Life Science
Seize the Golden Window for Biotech IPOs, Attovia Aims to Raise Up to $212.5 Million in Nasdaq Debut Life Science
Johnson & Johnson Quietly Completes Strategic Pivot, Targeting $50 Billion Cancer Drug Blueprint Life Science
After a 1,930% Decade, Should You Chase SMH or Rotate into SCHD? Financial Service, Life Science, Technology
Capital Expenditure Surge Reshapes Market Landscape as Funds Flee Tech Stocks for Value Opportunity in Healthcare Life Science, Technology
Moderna’s Market Value Exceeds Twenty Billion Dollars, Yet Ongoing Operating Losses and Competitive Pressures Continue to Trouble Investors Life Science
Bristol-Myers Squibb’s High Dividend Temporarily Backed by Financial Support, but Patent Cliff Poses Future Concerns Life Science
Tenet Healthcare Beats Q2 Expectations, Raises Full-Year Guidance, Sending Stock Up Over 17% Life Science
